US EditionVail Health New Psilocybin Vagus Nerve Study for Depression - Cannabis News World
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Psychedelic Mushrooms: Cancer and Depression, Hope? Internal Flux (silent) – Analyze of the Article Table of Contents Internal Flux (silent) – Analyze of the Article... The post Psychedelic Mushrooms: Cancer and Depression, Hope? appeared first on World News.
Study: Psilocybin Reduced Depression and Anxiety Symptoms in Mice Exposed to Chronic Stress
The Marijuana Herald - Marijuana news and information According to a study published in the journal Translational Psychiatry, psilocybin reduced key symptoms of depression and anxiety in mice subjected to chronic stress. Dried psilocybin mushrooms. “In the search for novel rapid-acting antidepressants, the psychedelic psilocybin has emerged as a promising therapy in several clinical trials”, states the study’s abstract. “However, its antidepress…
Vail Health New Psilocybin Vagus Nerve Study for Depression - Cannabis News World
Vail Health’s Behavioral Health Innovation Center has launched a pioneering clinical trial that combines psilocybin dosing with transcutaneous auricular vagus nerve stimulation (taVNS)—a non-invasive therapy—to amplify antidepressant effects in adults with major depressive disorder (MDD). This novel “OPTIMIZE” study began enrolling participants in April 2025 and aims to test whether the dual treatment can improve The post Vail Health New Psilocy…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
